(Q37576121)

21 August 2017

1 reference

title

Lipid lowering and aortic valve disease (English)

1 reference

21 August 2017

0 references

Anders G Olsson

1

1 reference

21 August 2017

publication date

1 September 2009

1 reference

Current Atherosclerosis Reports

21 August 2017

published in

1 reference

21 August 2017

volume

11

1 reference

21 August 2017

issue

5

1 reference

21 August 2017

page(s)

377-383

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-009-0057-z

21 August 2017

exact match

0 references

cites work

The metabolic syndrome

1 reference

12 December 2020

Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis

1 reference

12 December 2020

HMG CoA reductase inhibitor (statin) and aortic valve calcium

1 reference

12 December 2020

Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study

1 reference

12 December 2020

Intensive lipid-lowering therapy for patients with aortic stenosis

1 reference

12 December 2020

Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis

1 reference

12 December 2020

Does lowering cholesterol have an impact on the progression of aortic stenosis?

1 reference

12 December 2020

Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) tri

1 reference

12 December 2020

Is aortic stenosis a preventable disease?

1 reference

12 December 2020

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis

1 reference

12 December 2020

Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis

1 reference

12 December 2020

A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis

1 reference

12 December 2020

Age-associated aortic stenosis in apolipoprotein E-deficient mice.

1 reference

12 December 2020

Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies

1 reference

12 December 2020

Features of the Metabolic Syndrome and Diabetes Mellitus as Predictors of Aortic Valve Calcification in the Multi-Ethnic Study of Atherosclerosis

1 reference

12 December 2020

Valvular aortic stenosis in the elderly

1 reference

12 December 2020

Targeted therapy to prevent progression of calcific aortic stenosis

1 reference

12 December 2020

Long-term safety and efficacy of low-density lipoprotein apheresis in childhood for homozygous familial hypercholesterolemia

1 reference

12 December 2020

1 reference

12 December 2020

Calcific aortic stenosis: from bench to the bedside--emerging clinical and cellular concepts

1 reference

12 December 2020

Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves.

1 reference

12 December 2020

Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community

1 reference

12 December 2020

Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons

1 reference

12 December 2020

Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway

1 reference

12 December 2020

Molecular mechanisms underlying the onset of degenerative aortic valve disease

1 reference

12 December 2020

Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S11883-009-0057-Z

Identifiers

DOI

1 reference

21 August 2017

1 reference